The discussion started off with a look at Luxembourg’s covid vaccine strategy, and the welcome news that the AstraZeneca vaccine should be approved by the European Medicines Agency by the end of the month the government is even trying to get permission to get its allocation delivered before the official approval so that once approved it can be used right away. Indeed, as Duncan pointed out, Markus Ollert from the Luxembourg Institute of Health told Delano this week that we could reach a scenario where we can have a normal Christmas this year.
News this week that a petition to “Stop the privatization of public schools in Luxembourg” will be debated in parliamentary committee after it reached the requisite number of signatories was also a topic on the show.
Hesitant about receiving a covid-19 vaccine? Here are 10 points from a Luxembourg vaccine expert that could change your mind.
For Delano’s first Live Chat of the year on 20 January, journalist Jess Bauldry spoke to Markus Ollert, head of Luxembourg’s Institute of Health’s infection and immunity department.
He responded to some of the most common questions related to the new covid-19 vaccines, in terms of their safety, and effectiveness and how soon life can return to normal.
A normal Christmas in 2021?
We have to achieve 70% vaccination to develop herd immunity. But vaccine production has been slow because of production delays. Professor Ollert said these bottlenecks will likely be eased through collaborations between bio technology players, such as Sanofi, allowing producers like Pfizer/BionTech to use their production facilities.
Luxembourg s 1st HealthTech Incubator to Open in Spring chronicle.lu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chronicle.lu Daily Mail and Mail on Sunday newspapers.
Award Celebrates Molecular Pharmacology Studies at LIH
Dec 31 2020 Read 348 Times
The international 2019 Galien Prize in Pharmacology has been awarded to Luxembourg Institute of Health (LIH) scientists Dr Andy Chevigné and Dr Martyna Szpakowska from the LIH Department of Infection and Immunity (DII) for their outstanding contribution to molecular pharmacology.
Frank Vandenbroucke, Belgian Minister of Public Health and Social Affairs, along with representatives of pharmaceutical companies and healthcare hubs attended the virtual prize ceremony. The two LIH researchers were commended for their continuous achievements over the last eight years in advancing the understanding of the relevance, role, function and pharmacology of atypical chemokine receptors (ACKRs) and their ligands research activities and also for establishing and co-supervising the first molecular pharmacology academic laboratory in Luxembourg, which is located at the LIH Department of Infection and Immunity. The ma